Trials / Completed
CompletedNCT01511003
A Study is to Assess Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Who Showed Unsuccessful Response to Existing Disease Modifying Antirheumatic Drugs (DMARDs)
An Open- Label, Single-arm, Phase 4 Study to Assess the Efficacy and Safety of Tacrolimus in Active Rheumatoid Arthritis Patients Shown Unsuccessful Response Against DMARDs
- Status
- Completed
- Phase
- Phase 4
- Study type
- Interventional
- Enrollment
- 128 (actual)
- Sponsor
- Astellas Pharma Inc · Industry
- Sex
- All
- Age
- 20 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is to assess efficacy and safety of tacrolimus in active rheumatoid arthritis patients who showed unsuccessful response to existing DMARDs.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Tacrolimus | oral |
Timeline
- Start date
- 2011-12-05
- Primary completion
- 2015-05-11
- Completion
- 2015-05-11
- First posted
- 2012-01-18
- Last updated
- 2018-08-13
Locations
4 sites across 1 country: South Korea
Source: ClinicalTrials.gov record NCT01511003. Inclusion in this directory is not an endorsement.